Unique device identifier (udi#): in the absence of a reported part and lot number, the udi cannot be calculated.The device was not returned for evaluation.A review of the lot history record could not be conducted because the part and lot number was not provided.The reported patient effect of hypersensitivity is listed in the xience sierra everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary stenting procedures.A conclusive cause for the reported patient effect(s), and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
It was reported that an unspecified xience sierra stent was deployed in the morning; however, by the afternoon the patient had developed some eczema in the upper part of the body (arms and torso).The problem is persisting to this day.Topical treatment, corticotherapy, and uvb phototherapy has been provided as treatment.A biopsy and allergy test were performed and the results were negative for cobalt and chrome.No additional information was provided.
|